Harvoni Medication for Chronic Hepatitis C

Harvoni is a medication used to treat chronic hepatitis C virus (HCV) infection in adults. It is a combination of ledipasvir and sofosbuvir.
Category
Medication
Where to get
Available by prescription from healthcare providers and specialty pharmacies.
Prepared by Shruti Sahoo, reviewed by Dr. Eugene Smith

Harvoni FAQ

What is Harvoni used for?

Harvoni is a combination tablet containing ledipasvir and sofosbuvir. It may be used to treat certain genotypes of the hepatitis C virus in adults and children over the age of three.

Where can I find information about Harvoni?

Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Please see Important Facts about HARVONI including Important Warning. Discover HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg), a prescription medicine used to treat adults with chronic Hep C. See Important Safety Information, including Important Warning.

Does Harvoni treat hepatitis C?

If you have hepatitis C, your doctor may recommend treatment with Harvoni. It’s a prescription medication used to treat certain forms of hepatitis C in adults and some children. To learn more about how Harvoni is used to treat hepatitis C, see the section titled “ Is Harvoni used for hepatitis C? ” below.

Is there an alternative to Harvoni?

If you’re prescribed Harvoni, you may be curious about an alternative option such as Epclusa. Harvoni and Epclusa are both prescription drugs used to treat certain forms of hepatitis C in adults. Harvoni may also be used for treating hepatitis C in some children. If you’d like to learn more about these drugs, see this detailed comparison.

Does Harvoni contain ledipasvir and sofosbuvir?

Harvoni contains a combination of ledipasvir and sofosbuvir. Ledipasvir and sofosbuvir are antiviral medications that prevent the hepatitis C virus (HCV) from multiplying in your body. Harvoni is used to treat chronic hepatitis C in adults and children who are at least 3 years old.

What are Harvoni tablets?

HARVONI tablets are fixed-dose combination tablets containing ledipasvir and sofosbuvir for oral administration. Ledipasvir is an HCV NS5A inhibitor and sofosbuvir is a nucleotide analog inhibitor of HCV NS5B polymerase. Each 90 mg/400 mg tablet contains 90 mg ledipasvir and 400 mg sofosbuvir.

Harvoni References

If you want to know more about Harvoni, consider exploring links below:

Explore Related Topics

How can one ensure compliance with antiviral medication regimens for hepatitis treatment?

Share tips and strategies to help individuals adhere to their prescribed antiviral medication regimens for hepatitis treatment effectively.

What are the potential risks of long-term use of antiviral medications for hepatitis?

Examine the possible risks and complications associated with prolonged use of antiviral drugs for hepatitis treatment.

Dosage considerations for Interferon-based Antiviral Therapies in chronic viral hepatitis

Exchange insights on the dosage considerations for Interferon-based antiviral therapies in the management of chronic viral hepatitis.

How long does antiviral treatment typically last for hepatitis infections?

Discuss the usual duration of antiviral therapy for hepatitis and factors that may influence the length of treatment.

What should you consider before starting antiviral medication for hepatitis treatment?

Share insights on important factors to consider, such as potential side effects, drug interactions, and treatment duration, before beginning antiviral therapy for hepatitis.

Do new antiviral medications have the potential to revolutionize the treatment of chronic viral infections?

Engage in a discussion on how new antiviral medications hold the promise of transforming the management of chronic viral infections, offering improved outcomes and long-term therapeutic options.

Can antiviral medications cure hepatitis, or do they only manage the symptoms?

Discuss whether antiviral drugs have the potential to cure hepatitis infections or if they primarily help manage the symptoms.

What factors determine the choice of antiviral medication for hepatitis treatment?

Examine the factors that healthcare providers consider when choosing the most suitable antiviral medication for hepatitis treatment.

How have recent breakthroughs in antiviral medications impacted the treatment landscape?

Delve into the implications of recent breakthroughs in antiviral medications on the management of viral diseases, including improved efficacy, reduced side effects, and enhanced patient outcomes.

How do antiviral medications work to treat hepatitis infections?

Delve into the mechanism of action of antiviral drugs in treating hepatitis and understand how they combat the virus in the body.

What are the common side effects of antiviral medications for hepatitis?

Explore and discuss the common side effects associated with antiviral drugs used to treat hepatitis, and share tips on managing them.

How effective is antiviral combination therapy in treating resistant viruses?

Discuss the effectiveness of using multiple antiviral drugs to combat viral infections, especially in cases where single-drug treatments are no longer effective. Share insights, experiences, and research findings.

How effective is antiviral medication for treating hepatitis?

Discuss the effectiveness of antiviral drugs in managing hepatitis infections and share personal experiences or insights.

How does antiviral resistance develop?

Discuss the different ways in which antiviral resistance can develop in viruses and the impact it has on treatment options.